Description | Kaempferol 3-sophoroside-7-glucoside is a bioactive ingredient in the Lei leaves, belonging to the flavonoid group, which has antioxidant and anti-obesity activities. |
In vitro | The roasting process followed by a 30% EtOH extraction tended to enhance the content of kaempferol-3-sophoroside-7-glucoside. It effectively inhibited pancreatic lipase activity by 62.50 ± 4.81%, which was approximately 1.71 percentage points higher than that of the dried-nonroasted LCL extract (60.79 ± 3.75%). Its bioaccessible fraction obtained from in vitro digestion significantly and dose-dependently reduced intracellular lipid accumulation by adipocyte 3T3-L1 compared with a 30% EtOH extraction. At a concentration of 200 μg/mL, it inhibited lipid accumulation up to 29.55% in 3T3-L1 cells, which indicated that human digestive enzymes converted kaempferol-3-sophoroside-7-glucoside to kaempferol metabolites that have anti-obesity effects.[1] |
In vivo | Apigenin 7-O-β-D-glucopyranoside and kaempferol-3-sophoroside-7-glucoside, among others, were the main chemical constituents of Pteris wallichiana J. Agardh extract (PEW). In LPS-induced Raw264.7 inflammation and DSS-induced mouse colon UC, PEW pretreatment can significantly reduce the expressions of inflammatory cytokines in vitro and in vivo. In DSS-induced UC mice, PWE can improve the abnormal pathological tissue damage by inhibiting oxidative stress and inflammation-related signaling pathways, and improve the intestinal barrier function.[1] |
molecular weight | 772.66 |
Molecular formula | C33H40O21 |
CAS | 55136-76-0 |
Storage | store at low temperature,keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year |
References | 1. Choi EH, et al. Changes in the profiling of bioactive components with the roasting process in Lycium chinense leaves and the anti-obesity effect of its bioaccessible fractions. J Sci Food Agric. 2019;99(9):4482-4492. 2. Tao J, Huang Z, Wang Y, et al. Ethanolic Extract from Pteris wallichiana Alleviates DSS-Induced Intestinal Inflammation and Intestinal Barrier Dysfunction by Inhibiting the TLR4/NF-κB Pathway and Regulating Tight Junction Proteins. Molecules. 2022;27(10):3093. |